Examining the 340B Drug Pricing Program
House Committee on Energy and Commerce Subcommittee on Health Testimony on Examining the 340B Drug Pricing Program
March 24, 2015, 1:15 p.m.Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services